Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2022 | 0 | 2.499.810 | 1.449.994 | 1 | ||
2020 | 0 | 1.879.216 | 29.580 | 1 |
Total number of partners: 28
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 28
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2022-06-01 | Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage | GA-VAX | participant | 2.499.810 | 2 |
2020-06-01 | DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE | TRANSVAC-DS | participant | 1.879.216 | 28 |